National Cancer Institute; Notice of Closed Meeting, 50928 [06-7167]
Download as PDF
<![CDATA[
50928
Federal Register / Vol. 71, No. 166 / Monday, August 28, 2006 / Notices
Patent Status: U.S. Provisional
Application No. 60/617,340 filed 08 Oct
2004 (HHS Reference No. E–340–2004/
0-US–01); PCT Application No. PCT/
US05/3640 filed 07 Oct 2005 (HHS
Reference No. E–340–2004/2-PCT–01)
Licensing Status: Available for
exclusive and non-exclusive licensing.
Licensing Contact: Michelle A.
Booden, Ph.D.; 301/451–7337;
boodenm@mail.nih.gov
Collaborative Research Opportunity:
The NCI Surgery Branch is seeking
statements of capability or interest from
parties interested in collaborative
research to further develop, evaluate, or
commercialize the clinical applications
of T cell receptor technology. Please
contact Steven A. Rosenberg, M.D.,
Ph.D. at 301–496–4164 for more
information.
Dated: August 21, 2006.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E6–14184 Filed 8–25–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
mstockstill on PROD1PC61 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, CA07–002,
008, 009, Application of Emerging
Technologies for Cancer Research (STTR
R41/R42), (SBIR R43/44), (R21/R33, R21,
R33).
Date: October 18–19, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Administrator,
VerDate Aug<31>2005
15:09 Aug 25, 2006
Jkt 208001
Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd.,
Rm. 8057, Bethesda, MD 20892–8329. 301–
496–7421. kerwinm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: August 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–7167 Filed 8–25–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 07–07, Review R21.
Date: September 28, 2006.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Raj K. Krishnaraju, PhD,
MS, Scientific Review Administrator,
Scientific Review Branch, National Inst of
Dental & Craniofacial Research, National
Institutes of Health, 45 Center Dr., Rm 4AN
32J, Bethesda, MD 20892. 301–594–4864.
kkrishna@nidcr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 07–06, Review R03s, Ks.
Date: October 19, 2006.
Time: 10:30 a.m. to 1:30 p.m.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Raj K. Krishnaraju, PhD,
MS, Scientific Review Administrator,
Scientific Review Branch, National Inst of
Dental & Craniofacial Research, National
Institutes of Health, 45 Center Dr., Rm 4AN
32J, Bethesda, MD 20892. 301–594–4864.
kkrishna@nidcr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 07–17, Review R01.
Date: October 19, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Sooyoun (Sonia) Kim, MS,
45 Center Dr., 4An 32B, Division of
Extramural Research, National Inst. of Dental
& Craniofacial Research, National Institutes
of Health, Bethesda, MD 20892. (301) 594–
4827. kims@email.nidr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 07–08, Review of R21s.
Date: November 10, 2006.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Yujing Liu, MD, PhD,
Scientific Review Administrator, National
Institute of Dental & Craniofacial Res., 45
Center Drive, Natcher Building, Rm. 4AN38E,
Bethesda, MD 20892. (301) 594–3169.
yujing_liu@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 07–14, Review of R21.
Date: November 10, 2006.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Yujing Liu, MD, PhD,
Scientific Review Administrator, National
Institute of Dental & Craniofacial Res., 45
Center Drive, Natcher Building, Rm. 4AN38E,
Bethesda, MD 20892. (301) 594–3169.
yujing_liu@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; 07–09, Review R21s.
Date: November 21, 2006.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892. (Telephone Conference Call).
Contact Person: Yujing Liu, MD, PhD,
Scientific Review Administrator, National
Institute of Dental & Craniofacial Res., 45
Center Drive, Natcher Building, Rm. 4AN38E,
Bethesda, MD 20892. (301) 594–3169.
yujing_liu@nih.gov.
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 71, Number 166 (Monday, August 28, 2006)]
[Notices]
[Page 50928]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-7167]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, CA07-002, 008, 009, Application of Emerging Technologies for
Cancer Research (STTR R41/R42), (SBIR R43/44), (R21/R33, R21, R33).
Date: October 18-19, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Bethesda Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: C. Michael Kerwin, PhD, MPH, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Rm. 8057, Bethesda, MD 20892-8329. 301-496-7421.
kerwinm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: August 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-7167 Filed 8-25-06; 8:45 am]
BILLING CODE 4140-01-M
